Introduction
============

Bone defects are a common problem encountered in clinics worldwide, affecting the quality of life of patients and causing a tremendous socioeconomic burden. At present, various grafts utilized for bone repair and reconstruction still present unsatisfactory clinical requirements due to donor-site morbidity of autologous bone grafts, potential disease transmission, and immune rejection of allografts and xenografts, and inferior biological functionality of synthetic grafts. Recently, bone tissue engineering based on biomimetic scaffold materials has developed very rapidly and has provided a promising alternative for the repair and reconstruction of bone defects. It is vital to select ideal bone scaffold materials in bone tissue engineering strategies, which mainly depend on their physical and chemical properties.[@b1-ijn-13-7503] Firstly, a sufficient initial mechanical strength and stiffness must be provided to replace lost bone and to support the proliferation and differentiation of osteoblasts. Secondly, superior biocompatibility, biodegradation, and surface properties are all important aspects required for bone scaffold materials.[@b1-ijn-13-7503],[@b2-ijn-13-7503]

Mineralized collagen is recognized as the fundamental building block of bone scaffold materials as it has the hierarchically organized structure of natural bone.[@b3-ijn-13-7503]--[@b5-ijn-13-7503] Many efforts have been made to develop bone-like collagen/hydroxyapatite composites. However, previous studies have mainly focused on extrafibrillar mineralized collagen (EMC) fabricated by conventional crystallization methods, in which apatite crystallites are deposited randomly around the collagen fibrils. As natural bone needs to fit the variable mechanical demands via its hierarchically staggered nanostructure, the EMC can only produce similar chemical properties rather than the surface chemistry and nanostructure of bone extracellular matrix (ECM);[@b6-ijn-13-7503] therefore, the strength of EMC is insufficient.

Intrafibrillar mineralization has been demonstrated to be a crucial factor for native bone biomechanics; in addition, fabrication of mineralized collagen with intrafibrillar HA has been determined to imitate bone ECM. Based on the biomimetic strategy principle, a hierarchical and intrafibrillar mineralized collagen (IMC) with distinct nanostructures has been fabricated in our previous work and has been shown to be an ideal alternative bone scaffold material.[@b3-ijn-13-7503],[@b5-ijn-13-7503],[@b7-ijn-13-7503],[@b8-ijn-13-7503]

IMC bone scaffold materials have shown excellent capacities in promoting osteogenic differentiation and bone regeneration in previous work by us and others.[@b7-ijn-13-7503],[@b9-ijn-13-7503],[@b10-ijn-13-7503] However, most of our previous studies about this material were performed in vitro rather than in vivo. Furthermore, the exact biological processes and mechanisms involved in this IMC scaffold-guided bone regeneration (GBR) process are far from being elucidated, particularly at the cellular and molecular levels.

Therefore, the aims of this study were to evaluate the effects of IMC bone scaffold materials implanted in a critical-sized bone defect of a rat femur and to identify the biological processes and molecular mechanisms involved in this IMC-GBR process. It is expected that the present study will provide insight into the molecular mechanisms that occur during IMC-GBR, thus identifying the molecular targets that could be utilized to develop novel approaches for improving bone regeneration.

Materials and methods
=====================

Preparation of bone scaffold materials
--------------------------------------

Three types of bone scaffold materials were utilized in this study: group I, nano-hydroxyapatite (HA) materials; group II, EMC materials; and group III, IMC materials. The IMC samples utilized in this study were synthesized via an in vitro biomimetic mineralization process using hierarchical self-assembled nHA and collagen composite, as described previously.[@b5-ijn-13-7503],[@b7-ijn-13-7503],[@b11-ijn-13-7503] The EMC scaffold materials were fabricated by a conventional crystallization method.[@b6-ijn-13-7503] Samples were prepared with a pore size of 100--400 µm and a porosity of 85%--95%. The scaffolds used for the in vivo study were in the shape of a cylinder that was 5 mm in height and 4 mm in diameter; while for the in vitro study, they were in the shape of discs that were 1 mm in thickness and 12 mm in diameter. The surface topography for the HA, EMC, and IMC materials was visualized by scanning electron microscopy (Inspect F, FEI, Eindhoven, the Netherlands) and atomic force microscopy (Multimode and Dimension 3100, Varian, Palo Alto, CA, USA; [Figure 1](#f1-ijn-13-7503){ref-type="fig"}). The scaffolds exhibited a typical reticular pore structure for the HA materials, a pronounced fibrous structure for the IMC materials, and a rough texture with nano-apatite clusters randomly deposited around the fibrils in the EMC materials.

All experiments using animals were performed according to the Guidelines for the Care and Use of Laboratory Animals from the US National Institutes of Health and were approved by the Animal Care and Use Committee, Shanghai Jiao Tong University, Shanghai, China.

In vivo study
-------------

### Animal experimental design and surgical procedure

Male Sprague Dawley rats, weighing 280--300 g, were kept under standard conditions (controlled temperature: 22°C±2°C; humidity: 55%±5%; light--dark cycle: 12 hours/12 hours) with water and food available ad libitum, five rats per cage.

For the surgical procedure, the rats were anesthetized by an intraperitoneal injection of chloral hydrate (350 mg/kg body weight, Sigma-Aldrich Co., St Louis, MO, USA), and then the hair on the bilateral femur was removed. After exposure of the lower femoral joint, a cylindrical shape defect of 4 mm in diameter and 5 mm in depth was prepared on the distal femoral condyle.

A total of 36 animals with 72 femurs were randomly allocated into the following groups: 1) blank group (n=20); 2) nHA group (n=14); 3) EMC group (n=14); 4) IMC group (n=20); and 5) sham surgery group (n=4). For the blank group, the defect area was not filled with any graft material and was used as a blank control. For the nHA, EMC, and IMC groups, the corresponding scaffold material was implanted into the defects, respectively. For the sham group, a surgery was performed without a defect ([Figure 2](#f2-ijn-13-7503){ref-type="fig"}).

### Micro-computed tomography (µ-CT) evaluation

The femurs of each group (excluding the sham group, n=6/group) were harvested 10 weeks after the surgery and fixed in 4% neutral paraformaldehyde-buffered solution for 3 days before µ-CT evaluation. Then, a µ-CT system (Scanco Medical, Bassersdorf, Switzerland) was applied to scan the samples with the following parameters: voltage, 70 kV; electric current, 114 mA; and integration time, 700 ms. Subsequently, the parameters were set for three-dimensional reconstruction with an anisotropic voxel size of 10 µm as follows: σ=1.2, support=1, bone threshold=200, and scaffold threshold=700. The definition of the region of interest was determined with a cylindrical contour, taking into consideration the size of the defect (4.0 mm in diameter), and enlarged in the vertical direction to address all of the biomaterial and newly regenerated bone. Then, the ratio of bone tissue volume to total tissue volume (BV/TV) was calculated by the µ-CT image analysis software.

### Histological evaluation

After µ-CT scanning, the samples were decalcified with 14% ethylenediaminetetraacetic acid (EDTA) for 20 days and then subjected to gradual dehydration, paraffin infiltration, and embedding. Subsequently, 5-µm-thick sections were prepared, stained with HE, and visualized under a stereomicroscope (ECLIPSE E600, Nikon, Tokyo, Japan). Image-Pro Plus software (Media Cybernetics) was applied to calculate the ratio of regenerated new bone (n=6/group).

### Total RNA extraction and transcriptional profiling analysis

Specimens of regenerated tissues in the IMC and blank groups at 7 and 14 days after the surgery were harvested for transcriptional analysis (n=3/group at each time point). In brief, the regenerated tissue in the defect area was harvested with a trephine and homogenized in 1 mL of TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA). Total RNA of each sample was extracted utilizing an RNeasy Mini Kit (Qiagen NV, Venlo, the Netherlands). The RNA concentration was measured by a Nanodrop ND-2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturer's protocol. Then, the gene expression profiles were analyzed utilizing the Agilent Rat mRNA V3 (8\*60K, Design ID: 062716). Differentially expressed mRNAs were identified by the fold change as well as the *P*-value calculated with the *t*-test. The threshold for overexpressed genes was a fold change \>2.0 or \<2.0 and a *P*-value\<0.05. The gene functional classification tool Database for Annotation, Visualization and Integrated Discovery (DAVID) was applied for functional analysis of the differentially expressed genes by identifying the over-expressed gene ontology (GO) terms.

### Immunohistochemical analysis

The femurs of each group (n=4/group) were harvested for immunohistochemical analysis at 7 and 14 days, respectively, after the surgery. The tissue specimens were fixed in 4% paraformaldehyde, washed, dehydrated, embedded in paraffin, and then cut into 5-µm-thick sections. Anti-Wnt5a (ab174963, Abcam, Cambridge, MA, USA), anti-β-catenin (ab32572, Abcam), and anti-Axin2 (ab32197, Abcam) were selected as the primary antibodies. Negative control slides were prepared by omission of the primary antibody and incubation with 1% bovine serum albumin in PBS. Images were obtained under a light microscope (Leica DMI 6000B, Leica Microsystems, Wetzlar, Germany), and the relative proportions of positively stained cells were semiquantitated by the counting procedure applying a 40× objective. The number of cells/mm^2^ was determined and calculated with respect to the defect region.

In vitro study
--------------

### Cell culture and seeding

Rat bone marrow-derived mesenchymal stem cells (rBMSCs) were isolated from the femurs of 4-week-old Sprague Dawley rats (Animal Research Center, Shanghai Jiao Tong University, Shanghai, China) utilizing a well-established technique. rBMSCs were subsequently cultured in modified alpha-minimum essential medium (α-MEM; Hyclone, South Logan, UT, USA) supplemented with 10% fetal bovine serum in a humidified incubator containing an atmosphere of 5% CO~2~ at 37°C. Cells from passage 3 were used in subsequent experiments. Flow cytometric analysis was performed to confirm the immunophenotye of these cells utilizing fluorescein isothiocyanate-labeled antibodies against the rat antigens CD34, CD44, CD45, and CD90 (BioLegend, San Diego, CA, USA). Then, the cells were digested by trypsin and seeded at a density of 3×10^4^ cells/cm^2^ on the scaffold materials in 24-well plate (BD, Franklin Lakes, NJ, USA) for each group.

### Alkaline phosphatase (ALP) activity assay

ALP activity was assayed by an ALP assay kit (Sigma-Aldrich), according to the manufacturer's protocol, at 7 and 14 days. The activity was calculated by evaluating the absorbance at 520 nm using a microplate reader (n=5).

### Alizarin red S (ARS) staining

ARS staining was applied to evaluate the ECM calcium deposition by rBMSCs on the scaffold materials of each group for 21 days. Briefly, the samples were rinsed three times with PBS, fixed with 4% paraformaldehyde, and stained with 2% ARS solution. Then, the samples were visualized under a light microscope. The amount of dye released was quantified by a spectrophotometer after the ARS stain was released from the cell matrix (n=5).

### Real-time reverse transcription polymerase chain reaction for specific gene expression

After 3 and 7 days of culture, quantitative real-time transcription polymerase chain reaction (qRT-PCR) was applied to assess the mRNA expression of Wnt5a, β-catenin, and Axin2. GAPDH was used as a housekeeping gene. Real-time PCR was conducted with a SYBR^®^ Premix Ex TaqTM II kit (Takara, Kusatsu, Shiga Prefecture, Japan) utilizing an ABI-7300 Real-time PCR system (Thermo Fisher Scientific, Foster City, CA, USA). All procedures were conducted according to the manufacturer's protocol. Relative gene expression was calculated utilizing the 2^−ΔΔCt^ method (n=5). The primers were designed by primer 5.0 design primer software and commercially synthesized ([Table 1](#t1-ijn-13-7503){ref-type="table"}).

### Evaluation of rBMSCs on IMC scaffolds with the Wnt signaling pathway inhibitor Dkk1

The rBMSCs were seeded on IMC scaffolds as mentioned above, and then randomly divided into two groups: IMC group and IMC + Dickkofp-1 (Dkk1) group. For the IMC + Dkk1 group, 1 mL of α-MEM containing 10% fetal bovine serum and 100 ng/mL Dkk1 (recombinant mouse Dkk1 protein powder, Sigma-Aldrich) were added. While for the IMC group, α-MEM was added without Dkk1. ALP activity was assayed after coculture for 7 and 14 days, and the gene expression of Wnt5a, β-catenin, and Axin2 was evaluated by qRT-PCR at day 3, as mentioned above.

Statistical analysis
--------------------

All numerical data are expressed as the mean ± standard deviation, and GraphPad Software, Inc., La Jolla, CA, USA was used for statistical analysis. The statistical analyses of the results for the µ-CT, histological evaluation, ALP activity, ARS, and PCR were conducted with analysis of variance followed by Tukey's post hoc multiple comparison test. The analysis for ALP activity and the related gene expression between the IMC and IMC + Dkk1 groups was conducted with the unpaired Student's *t*-test. Differences were considered as statistically significant when *P*\<0.05.

For transcriptional analysis, the image data for the 12 samples were extracted utilizing BeadStudio and imported into GeneSpring for statistical analysis. Prior to statistical analysis, noisy data were discarded based on the values generated by the BeadStudio software to ensure that the gene was expressed above noise levels in any given treatment in a relatively reproducible way. Significant GO, set at *P*\<0.05, was corrected for multiple sampling using the method of Benjamini et al.[@b12-ijn-13-7503]

Results
=======

µ-CT and histological evaluation
--------------------------------

The capacities of the bone scaffold materials in promoting bone regeneration and maintaining the integrity of the defect space were assessed by µ-CT and histological evaluation. Ten weeks after implantation, reconstructed µ-CT showed that the defects were filled with fibrous bone structures, with the most material degradation in the IMC group. Whereas, in the HA and EMC groups, almost none or only a few scaffolds were degraded and a few newly formed bone structures could be observed in the pore structure of the scaffolds. In the defect group, only a few newly formed bone structures were found at the margin of the defects. The HE staining results were consistent with the µ-CT results, revealing that the defects were almost entirely filled with fibrous bone structures in the IMC group, with even the center of the defect showing obvious bone marrow formation ([Figure 3A](#f3-ijn-13-7503){ref-type="fig"}). Compared with the HA and EMC groups, more new bone formation was found in the IMC group, and the difference was significant (*P*\<0.05), according to the statistical analysis of the BV/TV ratio based on the µ-CT and HE staining results ([Figure 3B and C](#f3-ijn-13-7503){ref-type="fig"}).

Transcriptional profiling analysis
----------------------------------

During the IMC-GBR process, at day 7, a total of 501 genes were differentially expressed, with 252 upregulated and 249 downregulated; while at day 14, a total of 1,011 genes were differentially expressed, with 507 upregulated and 504 downregulated ([Table 2](#t2-ijn-13-7503){ref-type="table"}). The volcano plots of these statistically significant genes were built ([Figure 4](#f4-ijn-13-7503){ref-type="fig"}).

The functional significance of these differentially expressed genes was analyzed by GO analysis based on the DAVID tool ([Tables 3](#t3-ijn-13-7503){ref-type="table"} and [4](#t4-ijn-13-7503){ref-type="table"}). At day 7, most of the upregulated genes were related to inflammation and immune response as well as angiogenesis. At day 14, genes related to cell differentiation, developmental processes, and osteogenesis were all evidently upregulated. Furthermore, genes related to neurogenesis and Wnt signaling as well as genes related to regulation of Ras and Rho signal transduction were also found to be upregulated. Functionally, genes associated with osteogenesis and related with Wnt signaling pathways were regulated ([Table 5](#t5-ijn-13-7503){ref-type="table"}).

Wnt5a, β-catenin, and Axin2 protein expressions by immunohistochemical analysis
-------------------------------------------------------------------------------

Wnt5a, β-catenin, and Axin2 expressions were the most evident in the sham surgery group, while almost no positively stained cells were observed in the negative control group. Furthermore, more positive Wnt5a-, β-catenin-, and Axin2-stained cells were detected in the IMC group compared with the other groups, both at 7 and 14 days ([Figure 5](#f5-ijn-13-7503){ref-type="fig"} and [Table 6](#t6-ijn-13-7503){ref-type="table"}).

Verification of osteogenic potential of rBMSCs on different materials
---------------------------------------------------------------------

The rBMSCs in this study typically demonstrated a CD90^+^, CD44^+^, CD34^−^, and CD45^−^ immunophenotype ([Figure 6A--C](#f6-ijn-13-7503){ref-type="fig"}). The ALP activity of cells was higher in the IMC group (*P*\<0.05), compared with the HA and EMC groups after coculture for 7 days ([Figure 6D](#f6-ijn-13-7503){ref-type="fig"}). According to the ARS staining results, calcium deposition in the IMC group was evidently promoted after coculture for 21 days, compared with that in the HA and EMC groups (*P*\<0.05; [Figure 6E](#f6-ijn-13-7503){ref-type="fig"}).

mRNA expressions of Wnt5a, β-catenin, and Axin2
-----------------------------------------------

The mRNA expression levels of Wnt5a, β-catenin, and Axin2 were measured by qRT-PCR. It was shown that a consistent pattern of expression for all these genes was found, with the highest level of expression in response to IMC, followed by EMC and HA, both at days 3 and 7 (*P*\<0.05; [Figure 7](#f7-ijn-13-7503){ref-type="fig"}).

Evaluation of rBMSCs on IMC scaffolds with the Wnt signaling pathway inhibitor Dkk1
-----------------------------------------------------------------------------------

ALP activity was significantly decreased with Dkk1 in the IMC group at both 7 and 14 days (*P*\<0.05). Furthermore, the expression levels of Wnt5a, β-catenin, and Axin2 were all significantly decreased at day 3 after coculture with Dkk1 (*P*\<0.05; [Figure 8](#f8-ijn-13-7503){ref-type="fig"}).

Discussion
==========

In order to develop a promising bone scaffold material that imitates natural bone in terms of both structure and biological properties, it is critical to design scaffolds with nano- and microstructures similar to that of natural bone.[@b1-ijn-13-7503],[@b2-ijn-13-7503] The IMC scaffold materials utilized in this study were fabricated by the biomimetic strategy, showing a bone-like nanostructure. This is ascribed to the critical role of dual sequestration and nucleation analogs of noncollagenous proteins in recapitulating the hierarchical apatite arrangement within collagen fibrils.[@b5-ijn-13-7503],[@b10-ijn-13-7503] Meanwhile, the EMC scaffold materials, which were prepared by the conventional crystallization method, displayed a structure in which apatite was deposited around the fibrils randomly. Our findings are consistent with previous studies performed by our group and others.[@b4-ijn-13-7503],[@b5-ijn-13-7503],[@b10-ijn-13-7503]

In the present study, to assess the effects of different scaffold materials on bone regeneration, critical-sized defects were created in Sprague Dawley rat femurs with different materials grafted into them. After 10 weeks of grafting, µ-CT and HE staining analyses showed that the defects were almost entirely filled with regenerated bone in the IMC group, even at the center of the defect. This finding can be explained by the fact that the nanostructure of IMC promotes nutrients, blood supply, and osteogenic cell transfer throughout the scaffold. In comparison with the IMC group, less regenerated bone was found in the EMC and HA groups. In addition, in the group without any graft, the defect region was primarily filled with fibrous tissue with only a little new bone formation at the margin, indicating a reliable animal model. In the absence of such bone-like nanostructure, cells can only be attached to the outer margin of the scaffold, which blocks the penetration of nutrients, blood vessels, and osteogenic cells into the center of the scaffold, leading to a necrotic core.

The underlying mechanisms during this IMC-GBR process were further evaluated by the microarray technique. This technique has been applied to determine the gene expression profile and to elucidate the biological mechanisms in multiple cells or tissues, thus identifying the conserved development and regeneration processes. In our current study, 7 and 14 days were selected as the time points to explore the biological mechanisms taking place during the early regenerative process. This is a crucial period in the regenerative process for both early response mechanisms and the subsequent events involved in the initiation of osteogenesis within the defect. The selected time points are supported by the results, showing that the osteogenesis for new bones is significantly activated during this period.

At day 7, genes related to inflammatory and immune responses as well as angiogenesis were found to be overexpressed. This finding is consistent with the results from some similarly designed microarray studies of fracture healing[@b13-ijn-13-7503],[@b14-ijn-13-7503] and GBR.[@b15-ijn-13-7503]--[@b17-ijn-13-7503] The function of the immunoinflammatory response in bone regeneration is not fully clarified. It has been reported that regulation of this response may result in improved bone regeneration outcomes.[@b18-ijn-13-7503] Therefore, the exact function of the immunoinflammatory response during bone regeneration requires further studies, and it may represent a therapeutic target. The upregulation of angiogenic processes is not surprising as blood vessel formation is a well-known requirement for bone regeneration. Angiogenic factors may interact with osteogenic cells to facilitate bone formation.[@b19-ijn-13-7503],[@b20-ijn-13-7503] Thus, during the regenerative process, the nanostructure and topography of IMC may influence angiogenesis within the regeneration site. At day 14, the transcriptional profile is characteristic of a regenerating bone defect with the activation of a series of osteogenesis-related processes, including osteoclast and osteoblast differentiation, ossification, bone mineralization, and morphogenesis. Genes related to bone ECM (osteocalcin, Dmp1, collagen I, and collagen XIII), osteogenesis-related growth and differentiation factors (Bmp2), and transcriptional regulators of osteoblast function (Runx2, Sox6) were all upregulated. These findings are also consistent with the increased osteogenesis-related gene expression in bone fracture healing and GBR models at this time point.[@b14-ijn-13-7503],[@b15-ijn-13-7503],[@b17-ijn-13-7503] Furthermore, neurogenesis-related genes were upregulated, accompanied with the osteogenic process. This finding is also consistent with some microarray studies of GBR models,[@b15-ijn-13-7503],[@b17-ijn-13-7503] whereby neurogenesis-related gene expression was found to be prominent during the regenerative process. Although this gene expression may reflect different rates of nerve fiber regeneration within the defect, some studies of neuropeptide modulation of osteoblast differentiation indicate that neurogenesis-related genes may take an active role in enhancing bone regeneration.[@b21-ijn-13-7503]--[@b23-ijn-13-7503]

The Wnt signaling pathway, which is well known to play an active role in the various stages of osteogenesis,[@b24-ijn-13-7503],[@b25-ijn-13-7503] was the major pathway that was differentially regulated in this study. The full range of signaling factors, including ligands (Wnt5a), receptors (Fzd1, Fzd6, and Lrp5), cytoplasmic signal transduction molecules (Apc2, Dvl, and Pp3ca), nuclear transcription factors (Tcf3), transcription factors (Nfat5), and antagonists (Axin2 and Wif1) were differentially expressed. Furthermore, the Ras and Rho signaling pathways, which interact with the Wnt pathway, were also found to be upregulated. Both these pathways are associated with osteogenesis. Rho is a downstream modulator of Wnt signaling,[@b24-ijn-13-7503] while Ras-- MAPK signaling is related to osteoblast differentiation.[@b26-ijn-13-7503],[@b27-ijn-13-7503] The Wnt signaling pathway seems to play a central role in regulating this IMC-GBR. The effects of Wnt signaling pathways in IMC-GBR were further investigated in an effort to find possible molecular mechanisms for promoting bone regeneration. Wnt5a is one of the most important Wnt protein members and was found to be upregulated in our study, with a higher fold change. Axin2 has been demonstrated to be the most precise reporter in the Wnt pathway as it is a direct target gene of Wnt ligand binding and activation of the Wnt pathway.[@b28-ijn-13-7503],[@b29-ijn-13-7503] β-catenin is also a crucial member of the Wnt/β-catenin pathway, although its expression is not directly linked to activation of the Wnt pathway per se, but rather from posttranslational modifications that inhibit its cytoplasmic degradation as the result of the upstream activation of the pathway.[@b30-ijn-13-7503],[@b31-ijn-13-7503] Dkk1 is a member of the Dickkopf family, which can inhibit the canonical Wnt signaling pathway by preventing formation of the Wnt--Fzd--Lrp complex.[@b32-ijn-13-7503],[@b33-ijn-13-7503] In this study, IMC bone scaffolds had the effect of significantly upregulating the expression of Wnt-related factors (Wnt5a, β-catenin, and Axin2), both in vivo and in vitro, compared with the HA and EMC scaffolds. It was also shown that with the addition of Dkk1, the osteogenic differentiation capacity and the expression of Wnt-related factors of rBMSCs were significantly decreased. It appears fair to speculate that the underlying mechanism behind the enhanced bone regeneration in the presence of IMC scaffolds may be directly linked to activation of the Wnt signaling pathway.

This study demonstrated insight into the multiple biological mechanisms involved in IMC-GBR; however, there were some limitations. Particularly, it was difficult to fully identify the temporal and spatial characteristics of the transcriptional profile. First, only two time points were chosen, so the results can only be clarified in the context of overexpressed genes between these two time points. Additionally, the harvested tissue comprised various cell types, making it impractical to attribute a specific molecular mechanism to an individual cell type and difficult to localize the source of the gene expression within the defects. In order to modify the IMC scaffolds for functional bone regeneration, further identification of the specific gene functions in the regenerative process in future investigations will be considered. In addition, earlier and later time points should also be analyzed.

Conclusion
==========

IMC bone scaffold materials can significantly enhance bone regeneration through activation of Wnt signaling pathways. This investigation suggests that IMC scaffolds can provide an ideal microenvironment to regulate osteogenic cell differentiation and to improve bone regeneration with a nanostructure similar to native bone. Therefore, IMC scaffolds have potential for use in bone tissue engineering applications. Although analysis of the underlying molecular mechanisms was preliminary and further investigations are still required, this study enhanced our knowledge of the factors required for IMC-GBR and provided us with targets for promoting bone regeneration.
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![The macroscopic and surface topography images.\
**Note:** HA (**A**, **D**), EMC (**B**, **E**), and IMC (**C**, **F**) visualized by SEM and AFM, individually.\
**Abbreviations:** AFM, atomic force microscopy; EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen; SEM, scanning electron microscopy.](ijn-13-7503Fig1){#f1-ijn-13-7503}

![Surgical procedures.\
**Notes:** (**A**) Critical-sized defects created on a rat femur. (**B**) Bone scaffold materials implanted into the defect.](ijn-13-7503Fig2){#f2-ijn-13-7503}

![Analysis of in vivo bone regeneration effects of different bone scaffold materials.\
**Notes:** (**A**) Representative µ-CT and HE staining images of defect regions after implantation with blank, HA, EMC, and IMC scaffolds for 10 weeks. (**B**) New BV relative to the TV within the defect region from different groups based on µ-CT analysis. (**C**) Semiquantitative analysis of new bone based on histologic examination. \**P*\<0.05 vs IMC; &*P*\<0.05 vs EMC; ^\#^*P*\<0.05 vs all of the other groups.\
**Abbreviations:** µ-CT, micro-computed tomography; BV, bone tissue volume; EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen; NB, new bone; OB, old bone; S, scaffold materials; TV, total tissue volume; F, fibrous tissue.](ijn-13-7503Fig3){#f3-ijn-13-7503}

![The volcano plots of differentially expressed genes between IMC and blank groups.\
**Notes:** (**A**) At day 7. (**B**) At day 14. Red points indicate mRNAs with a fold change of ≥2.0 and a *P*-value ≤0.05. Blue points indicate mRNAs with a fold change of ≤2.0 and a *P*-value of ≤0.05.\
**Abbreviation:** IMC, intrafibrillar mineralized collagen.](ijn-13-7503Fig4){#f4-ijn-13-7503}

![Immunohistochemical analysis of positively stained cells in the defect regions of different groups.\
**Notes:** (**A**) At day 7. (**B**) At day 14. (**C**) The sham surgery group without primary antibody was used as a NC. Black arrows indicate positively stained cells.\
**Abbreviations:** EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen; NC, negative control; OB, old bone; S, scaffold materials.](ijn-13-7503Fig5){#f5-ijn-13-7503}

![In vitro osteogenic differentiation capacity of rBMSCs on different materials.\
**Notes:** (**A**) Primary rBMSCs. (**B**) rBMSCs of passage 3. (**C**) Flow cytometric analysis of rBMSCs. (**D**) ALP activity assay after coculture for 7 and 14 days. (**E**) ARS staining of rBMSCs cultured on HA, EMC, and IMC for 21 days. \**P*\<0.05 vs HA, ^\#^*P*\<0.05 vs EMC.\
**Abbreviations:** ALP, alkaline phosphatase; ARS, alizarin red S; EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen; rBMSCs, rat bone marrow-derived mesenchymal stem cells.](ijn-13-7503Fig6){#f6-ijn-13-7503}

![qRT-PCR for specific gene expression.\
**Notes:** Fold change in expression of Wnt5a, β-catenin, and Axin2 on different materials after coculture for 3 and 7 days. \**P*\<0.05 vs HA, ^\#^*P*\<0.05 vs EMC.\
**Abbreviations:** EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen; qRT-PCR, quantitative real-time transcription polymerase chain reaction.](ijn-13-7503Fig7){#f7-ijn-13-7503}

![Evaluation of rBMSCs on IMC scaffolds with the Wnt signaling pathway inhibitor Dkk1.\
**Notes:** (**A**) ALP activity assay at days 7 and 14. (**B**) Fold change in expression of Wnt5a, β-catenin, and Axin2 at day 3. \**P*\<0.05 vs IMC.\
**Abbreviations:** ALP, alkaline phosphatase; Dkk1, Dickkopf-1; IMC, intrafibrillar mineralized collagen; rBMSCs, rat bone marrow-derived mesenchymal stem cells.](ijn-13-7503Fig8){#f8-ijn-13-7503}

###### 

Primers for qRT-PCR

  Gene        Forward primer (5′--3′)     Reverse primer (5′--3′)
  ----------- --------------------------- -------------------------
                                          
  GAPDH       GGTGAAGGTCGGAGTCAACGG       GGTCATGAGTCCTTCCACGAT
  Wnt5a       TCTCAGCCCAAGCAACAAGG        GCCAGCATCACATCACAACAC
  β-Catenin   GCTACTGTTGGATTGATTCGAAATC   CCCTGCTCACGCAAAGGT
  Axin2       CCCCAAAGCAGCGGTGC           GCGTGGACACCTGCCAG

**Abbreviation:** qRT-PCR, quantitative real-time transcription polymerase chain reaction.

###### 

Numbers of differentially expressed genes at days 7 and 14

           Numbers of differentially significant genes         
  -------- --------------------------------------------- ----- -------
                                                               
  Day 7    252                                           249   501
  Day 14   507                                           504   1,011

###### 

Overexpressed GO categories of biological processes at day 7

  Term ID and description                                                      Count   *P*-value
  ---------------------------------------------------------------------------- ------- -----------
                                                                                       
  **Downregulated**                                                                    
  GO:0050731--positive regulation of peptidyl-tyrosine phosphorylation         12      2.64E--06
  GO:0019221--cytokine-mediated signaling pathway                              10      2.10E--05
  GO:0001666--response to hypoxia                                              13      0.000331
  GO:0006886--intracellular protein transport                                  8       0.00646
  GO:0050918--positive regulation of protein kinase B signaling                8       0.0144
  GO:0045779--negative regulation of bone resorption                           4       0.0351
  GO:0006508--proteolysis                                                      5       0.0419
  **Upregulated**                                                                      
  GO:0006954--inflammatory response                                            9       2.04E--05
  GO:0009611--response to wounding                                             15      4.73E--05
  GO:0002526--acute inflammatory response                                      13      0.000158
  GO:0006955--immune response                                                  15      0.000827
  GO:0001525--angiogenesis                                                     11      0.000985
  GO:0019882--antigen processing and presentation                              6       0.00451
  GO:0008284--positive regulation of cell proliferation                        10      0.00508
  GO:0006953--acute-phase response                                             5       0.00797
  GO:0042088--T-helper 1 type immune response                                  6       0.0105
  GO:0030101--natural killer cell activation                                   4       0.0122
  GO:0007155--cell adhesion                                                    7       0.0164
  GO:0042060--wound healing                                                    5       0.0288
  GO:0051092--positive regulation of NF-kappaB transcription factor activity   5       0.0394
  GO:0007599--hemostasis                                                       3       0.0402
  GO:0007568--aging                                                            4       0.0413

**Abbreviation:** GO, gene ontology.

###### 

Overexpressed GO terms of biological processes at day 14

  Term ID and description                                                     Count   *P*-value
  --------------------------------------------------------------------------- ------- -----------
                                                                                      
  **Downregulated**                                                                   
  GO:0071347--cellular response to interleukin-1                              17      2.24E--06
  GO:0001913--T cell-mediated cytotoxicity                                    11      4.51E--05
  GO:0070374--positive regulation of ERK1 and ERK2 cascade                    7       0.000271
  GO:0003009--skeletal muscle contraction                                     4       0.000431
  GO:0002548--monocyte chemotaxis                                             5       0.00227
  GO:0060389--pathway-restricted SMAD protein phosphorylation                 3       0.00316
  GO:0048535--lymph node development                                          4       0.0164
  GO:0014823--response to activity                                            3       0.0287
  GO:0006816--calcium ion transport                                           5       0.0354
  GO:0045453--bone resorption                                                 3       0.0359
  GO:0034141--positive regulation of toll-like receptor 3 signaling pathway   2       0.0477
  **Upregulated**                                                                     
  GO:0048856--anatomical structure development                                21      3.37E--05
  GO:0032502--developmental process                                           18      8.16E--05
  GO:0048468--cell development                                                17      0.000871
  GO:0016055--Wnt signaling pathway                                           11      0.000960
  GO:0001501--skeletal system development                                     13      0.00104
  GO:0007399--nervous system development                                      14      0.00116
  GO:0030154--cell differentiation                                            9       0.00189
  GO:005087--neurological system process                                      11      0.0182
  GO:0060348--bone development                                                10      0.00209
  GO:0090263--positive regulation of canonical Wnt signaling pathway          4       0.00237
  GO:0060349--bone morphogenesis                                              5       0.00366
  GO:0030316--osteoclast differentiation                                      7       0.00482
  GO:0001503--ossification                                                    5       0.00578
  GO:0031100--organ regeneration                                              5       0.00764
  GO:0016477--cell migration                                                  7       0.0103
  GO:0060070--canonical Wnt signaling pathway                                 4       0.0156
  GO:0030111--regulation of Wnt receptor signaling pathway                    4       0.0211
  GO:0030278--regulation of ossification                                      3       0.0225
  GO:0051216--cartilage development                                           4       0.0241
  GO:0007218--neuropeptide signaling pathway                                  3       0.0273
  GO:0007266--Rho protein signal transduction                                 3       0.0288
  GO:0030282--bone mineralization                                             4       0.0304
  GO:0046578--regulation of Ras protein signal transduction                   3       0.0417

**Abbreviation:** GO, gene ontology.

###### 

List of differentially expressed genes (*P*\<0.05) belonging to functionally relevant GO terms (positive value indicates upregulated genes)

  Gene symbol                 Gene name                                                           Fold change
  --------------------------- ------------------------------------------------------------------- -------------
                                                                                                  
  **Skeletal development**                                                                        
  Acan                        Aggrecan 1                                                          6.1
  Axin2                       Axin2                                                               4.3
  Bglap                       Bone γ-carboxyglutamate(gla) protein (osteocalcin)                  3.4
  Bmp2                        Bone morphogenetic protein 2                                        2.7
  Bmpr1a                      Bone morphogenetic protein receptor, type IA                        3.6
  COL1A2                      Procollagen, type, 1 α2                                             2.8
  COL3A1                      Collagen, type XIII, α1                                             3.1
  DMP1                        Dentin matrix protein 1                                             12.4
  Jund                        Jun D proto-oncogene                                                2.2
  Hoxc10                      Homeo box C10                                                       −3.2
  Mmp8                        Matrix metallopeptidase 8                                           3.1
  Runx2                       Runt-related transcription factor 2                                 6.3
  Sox6                        Sry-box containing gene 6                                           3.9
  Sp1                         Sp1 transcription factor                                            2.8
  Igf2                        Insulin-like growth factor 2                                        3.7
  Wnt5a                       Wingless-type MMTV integration site family, member 5A               4.7
  Zfand5                      Zinc finger, AN1-type domain                                        2.1
  **Wnt signaling pathway**                                                                       
  Apc2                        Adenomatous polyposis coli                                          2.3
  Axin2                       Axin2                                                               4.3
  Ccnd1                       Cyclin D1                                                           2.4
  Dkk1                        Dickkopf1 homolog (*Xenopus laevis* )                               3.4
  Dvl1                        Disheveled, dsh homologue 1 (*Drosophila*)                          2.2
  Fzd1                        Frizzled-1                                                          2.6
  Fzd6                        Frizzled-6                                                          3.2
  Lrp5                        Low-density lipoprotein receptor-related protein 5                  2.8
  Nfat5                       Nuclear factor of activated T-cells 5                               2.4
  Ppp3ca                      Protein phosphatase 3 (formerly 2B), catalytic subunit, a-isoform   3.1
  Tcf3                        Transcription factor 3                                              2.1
  Sfr4                        Secreted frizzled-related protein 4                                 2.3
  Wnt5a                       Wingless-type MMTV integration site family, member 5A               5.7
  Wif1                        Wnt inhibitory factor 1                                             −3.1

**Abbreviation:** GO, gene ontology.

###### 

Immunohistochemical analysis of positively stained cells in the defects region

              Blank   HA   EMC   IMC    Sham
  ----------- ------- ---- ----- ------ -------
                                        
  Wnt5a                                 
  --                                    +++++
  7 days      \+      \+   ++    +++    
  14 days     \+      ++   +++   ++++   
  β-Catenin                             
  --                                    +++++
  7 days      \+      \+   ++    +++    
  14 days     \+      \+   +++   ++++   
  Axin2                                 
  --                                    +++++
  7 days      \+      \+   +++   +++    
  14 days     \+      ++   +++   ++++   

**Notes:** +, 1--100 cells/mm^2^; ++, 101--200 cells/mm^2^; +++, 201--400 cells/mm^2^; ++++, 401--800 cells/mm^2^; +++++, \>800 cells/mm^2^.

**Abbreviations:** EMC, extrafibrillar mineralized collagen; HA, nano-hydroxyapatite; IMC, intrafibrillar mineralized collagen.
